Good Pharma Scorecard

We rank companies on ethics and social responsibility performance criteria, focusing on issues that are critical to patients and public health.

The Good Pharma Scorecard ranks companies on their bioethics and social responsibility performance, taking into account ethics and legal standards. Measures evaluate the integrity of clinical trial designs, the accessibility of medicines, marketing practices, diversity and fair inclusion, among other ethics and human rights issues. Below is a sample of our transparency and data sharing rankings.

Transparency and Data Sharing are
Important for Life Sciences Companies:

Transparency in research and marketing help protect and respect trial participants and medicine and vaccine consumers

Sound marketing practices and evidenced based medicine require product safety and efficacy data be in the public domain

Being able to learn from what other scientists have already done- both accomplishments and failures- stimulates innovation and ultimately the delivery of lifesaving products.

Transparency is key to maximizing the value of trial data and people’s participation in research

Opacity can drive up costs of research and care

Transparency and data-sharing enable validation and replication of study findings

Rankings

View Good Pharma Scorecard rankings by

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Addyi Valeant / Sprout Hypoactive Sexual Desire Disorder
Valeant / Sprout
Hypoactive Sexual Desire Disorder
# 1 Alecensa Roche Lymphoma & Lung Cancer
Roche
Lymphoma & Lung Cancer
# 1 Bridion Merck Neuromuscular Blockade
Merck
Neuromuscular Blockade
# 1 Corlanor Amgen Heart Failure
Amgen
Heart Failure
# 1 Cotellic Roche / Genentech Melanoma
Roche / Genentech
Melanoma
# 1 Daklinza Bristol-Myers Squibb Hepatitis C
Bristol-Myers Squibb
Hepatitis C
# 1 Entresto Novartis Heart Failure
Novartis
Heart Failure
# 1 Farydak Novartis Multiple Myeloma
Novartis
Multiple Myeloma
# 1 Genvoya Gilead HIV
Gilead
HIV
# 1 Ibrance Pfizer Breast Cancer
Pfizer
Breast Cancer
# 1 Odomzo Novartis Basal Cell Carcinoma
Novartis
Basal Cell Carcinoma
# 1 Tagrisso AstraZeneca Lung Cancer
AstraZeneca
Lung Cancer
# 1 Tresiba/ Ryzodeg Novo Nordisk Diabetes Mellitus
Novo Nordisk
Diabetes Mellitus
100% Median Median score

Median: 100%

# 14 Yondelis Johnson & Johnson / Janssen Liposarcoma & Leiomyosarcoma
Johnson & Johnson / Janssen
Liposarcoma & Leiomyosarcoma
# 15 Zurampic AstraZeneca / Ardea Hyperuricemia with Gout
AstraZeneca / Ardea
Hyperuricemia with Gout
# 16 Kybella Allergan / Kythera Double Chin
Allergan / Kythera
Double Chin
# 17 Avycaz Allergan / Cerexa Intra-abdominal & UTI Infections
Allergan / Cerexa
Intra-abdominal & UTI Infections
# 18 Viberzi Allergan / Forest IBS
Allergan / Forest
IBS
# 18 Vraylar Allergan / Forest Schizophrenia / Bipolar Disorder
Allergan / Forest
Schizophrenia / Bipolar Disorder